Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for AlertsDetails
Title
Grant Type
Focus Area
Country
Application Due Date
Community Oncology Support for Therapy Management in Multiple Myeloma (MM)
Release Date:
Review Process: Pfizer Internal
Education Oncology USA
Management of Adults and Adolescents with Alopecia Areata
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Sickle Cell Disease Transition in Care
Release Date:
Partner: National Alliance of Sickle Cell Centers
Review Process: Expert Review Panel
Quality Improvement Rare Disease USA
Title
Grant Type
Focus Area
Country
Application Due Date
Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer
Release Date:
Partner:

NCCN

Review Process: Expert Review Panel
Research Oncology All, USA
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs
Release Date:
Review Process: Pfizer Internal
Education Oncology All
NSCLC – Current Practice Considerations
Release Date:
Review Process: Pfizer Internal
Education Oncology Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom
Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin America
Release Date:
Review Process: Pfizer Internal
Research Hospital Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay
Addressing Health Disparities in Inflammatory Bowel Disease
Release Date:
Review Process: Expert Review Panel
Quality Improvement Inflammation & Immunology USA
Enduring SpA Programs
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Atopic Dermatitis Patient Education
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology USA
Knowledge Gaps in Updated Pneumococcal Immunization Recommendations
Release Date:
Review Process: Pfizer Internal
Education Vaccines USA
Prostate Cancer Disparities Project
Release Date:
Partner:

American Cancer Society

Review Process: Expert Review Panel
Quality Improvement Oncology USA
Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All
Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets)
Release Date:
Review Process: Pfizer Internal
Education Inflammation & Immunology All